कंपनी का अवलोकन
Community Health Systems, Inc. (CYH) is a prominent entity within the Healthcare sector, specifically operating in the Medical Care Facilities industry, where it owns, leases, and manages general acute care hospitals across the United States. The organization provides a comprehensive suite of medical services including general acute care, emergency room support, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic imaging, psychiatric care, and rehabilitation services to its patient base. This healthcare infrastructure supports approximately 44,000 employees, reflecting a significant operational footprint in the delivery of essential medical services nationwide. The company's current market capitalization stands at $443.93M, while its trailing twelve-month revenue reaches $12.49B, figures that collectively indicate a substantial scale of operations despite a relatively modest valuation multiple relative to its revenue stream.
वित्तीय स्वास्थ्य
The company generated $12.49B in revenue over the trailing twelve months, with a net income of $509.00M and an EBITDA of $1.45B, highlighting a robust operational cash generation capability before interest, taxes, depreciation, and amortization expenses. The significant gap between the $12.49B revenue and the $509.00M net income reveals a cost structure where operating expenses consume approximately 95.9% of total sales, leaving a profit margin of 4.1% which underscores the capital-intensive nature of hospital operations. Free cash flow stands at $395.25M, indicating that after capital expenditures, the company retains substantial liquidity to fund ongoing maintenance, debt servicing, or potential strategic acquisitions without external financing. The gross margin is reported at 41.7%, while the operating margin sits at 9.2%, and the profit margin is 4.1%, suggesting that while the core service delivery is profitable, overhead costs such as salaries and regulatory compliance heavily impact the bottom line. In terms of balance sheet leverage, the company holds $260.00M in cash against total debt of $11.04B, resulting in a highly leveraged position given the absence of a reported Debt to Equity ratio in the available data. The current ratio of 1.47 suggests that the company maintains adequate short-term liquidity to cover its immediate obligations, as current assets are 1.47 times the value of current liabilities. Return on Assets is recorded at 5.0%, while Return on Equity is listed as N/A, implying that management generates a modest return on the total asset base but faces challenges in generating equity returns likely due to the high debt levels affecting the denominator in the ROE calculation.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is 0.84, whereas the forward P/E is -370.59, a stark disparity that implies the market expects earnings to decline significantly or turn negative in the near future, rendering the forward multiple statistically anomalous for traditional valuation analysis. The price-to-book ratio stands at -0.30, indicating that the market values the company at a fraction of its book value, which often occurs when substantial intangible liabilities or goodwill impairments affect the equity value. The price-to-sales ratio is 0.04, and the EV/EBITDA multiple is 8.13, suggesting that while the stock trades at a negligible fraction of its sales revenue, the enterprise value relative to earnings before interest, taxes, depreciation, and amortization remains within a range that could be considered moderate for a highly leveraged healthcare operator. The 52-week high for the stock is $4.47 and the 52-week low is $2.26, providing a trading range where the current price dynamics must be analyzed against these historical bounds to assess relative positioning. Although the exact current share price is not explicitly stated in the provided facts, the negative forward P/E and low P/B suggest the stock is trading well below intrinsic value estimates based on assets, potentially reflecting market concerns over the debt burden and earnings trajectory.
Growth & Income
Revenue growth year-over-year is recorded at -4.9%, while earnings growth is listed as N/A, indicating that the company has recently contracted in terms of top-line sales, and the lack of reported earnings growth data prevents a direct comparison of earnings expansion relative to revenue contraction. The absence of a dividend yield and a payout ratio of 0.0% confirms that Community Health Systems, Inc. does not distribute cash to shareholders, meaning the company retains all its earnings to service its significant debt obligations of $11.04B and fund operational capital needs rather than paying dividends. Given the zero payout ratio and negative revenue growth, the company's primary strategy appears to be preserving liquidity and reducing leverage rather than rewarding shareholders with income distributions. The overall growth and income profile is characterized by a contraction in revenue, a complete absence of dividend income, and a valuation environment marked by negative forward multiples, reflecting a challenging period for this medical care facility operator.